Resilience notches $410M in federal financing to bolster production
Biopharma manufacturer Resilience has netted a major investment from the US Department of Defense.
Resilience inked a financing agreement for a $410 million long-term loan from the DOD, working with the US International Development Finance Corporation. The loan will be used to bolster Resilience’s domestic biomanufacturing capacity and capabilities for several products, according to a press release. This includes biologics such as antibodies, proteins, vaccines and mRNA products.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.